Please enable JavaScript to continue using this application.

Compare tickers

Valuation, margins, and growth side by side.

Compare $BMY vs $VTRS | Chartloom

Compare

$BMY vs $VTRS

Bristol-Myers Squibb Co · Viatris Inc

BMY

Bristol-Myers Squibb Co

VTRS

Viatris Inc

Compare $BMY vs $VTRS

Comparing Bristol-Myers Squibb Co and Viatris Inc

BMYBristol-Myers Squibb Co

VTRSViatris Inc

BMYBristol-Myers Squibb Co

Market cap

$115.72B

P/E (TTM)

12.50x

Forward P/E (NTM)

8.72x

Forward P/S (NTM)

2.37x

Rev growth (TTM)

38.5%

YTD performance

6.0%

52W performance

28.9%

FCF yield

14.4%

VTRSViatris Inc

Market cap

$20.09B

P/E (TTM)

—

Forward P/E (NTM)

6.60x

Forward P/S (NTM)

1.33x

Rev growth (TTM)

4.4%

YTD performance

38.4%

52W performance

77.1%

FCF yield

9.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BMY

VTRS

Detailed metrics comparison

BMY

Bristol-Myers Squibb Co

VTRS

Viatris Inc

Market Cap

BMY$115.72B

VTRS$20.09B

Enterprise Value

BMY$150.12B

VTRS$32.55B

Price

BMY$56.67

VTRS$17.25

P/E Ratio

BMY12.50x

VTRSN/A

P/S Ratio

BMY2.35x

VTRS1.36x

EV/Sales

BMY3.05x

VTRS2.21x

EV/EBITDA

BMY6.41x

VTRS8.00x

P/B Ratio

BMY5.41x

VTRS1.42x

P/FCF Ratio

BMY6.93x

VTRS11.09x

EV/FCF

BMY9.00x

VTRS17.96x

PEG Ratio

BMYN/A

VTRSN/A

Forward P/E (NTM)

BMY8.72x

VTRS6.60x

Forward P/S (NTM)

BMY2.37x

VTRS1.33x

Revenue (TTM)

BMY$49.19B

VTRS$14.74B

Revenue Growth (YoY)

BMY38.5%

VTRS4.4%

Forward Rev Growth

BMY-3.1%

VTRS2.0%

Gross Margin (TTM)

BMY71.7%

VTRS40.3%

Operating Margin (TTM)

BMY25.5%

VTRS0.0%

EBITDA Margin (TTM)

BMY46.1%

VTRS27.2%

Net Margin (TTM)

BMY18.9%

VTRS-2.8%

FCF Margin (TTM)

BMY33.9%

VTRS12.3%

Net Income (TTM)

BMY$9.28B

VTRS$-411M

FCF (TTM)

BMY$16.69B

VTRS$1.81B

EPS (TTM)

BMY$4.53

VTRS-$0.35

ROE (TTM)

BMY46.8%

VTRS-279.0%

ROA (TTM)

BMY10.3%

VTRS-112.0%

ROIC (TTM)

BMY14.2%

VTRS-142.0%

Cash

BMY$8.72B

VTRS$887M

Debt

BMY$43.12B

VTRS$13.35B

Net Cash/Debt

BMY$-34.40B

VTRS$-12.46B

Current Ratio (TTM)

BMY1.53x

VTRS1.58x

Quick Ratio (TTM)

BMY1.39x

VTRS0.83x

Debt/Equity (TTM)

BMY1.93x

VTRS0.94x

Debt/Assets (TTM)

BMY0.0%

VTRS0.0%

Interest Coverage (TTM)

BMYN/A

VTRSN/A

Net Debt/EBITDA (TTM)

BMY0.00x

VTRS0.00x

Beta

BMY0.18

VTRS0.89

52W Performance

BMY28.9%

VTRS77.1%

YTD Performance

BMY6.0%

VTRS38.4%

% from 52W High

BMY-17.4%

VTRS-6.4%

% from 52W Low

BMY33.3%

VTRS77.3%

Asset Turnover (TTM)

BMY0.54x

VTRS0.40x

FCF Yield (TTM)

BMY14.4%

VTRS9.0%

Earnings Yield (TTM)

BMY8.0%

VTRS-2.0%

Dividend Yield (TTM)

BMY6.3%

VTRS2.7%

Rule of 40

BMY72.5

VTRS16.7

EV/GP/RG

BMYN/A

VTRS1.97

Ticker research

View BMY research View VTRS research

Metric	BMY Bristol-Myers Squibb Co	VTRS Viatris Inc
Market & Valuation
Market Cap	$115.72B	$20.09B
Enterprise Value	$150.12B	$32.55B
Price	$56.67	$17.25
P/E Ratio	12.50x	N/A
P/S Ratio	2.35x	1.36x
EV/Sales	3.05x	2.21x
EV/EBITDA	6.41x	8.00x
P/B Ratio	5.41x	1.42x
P/FCF Ratio	6.93x	11.09x
EV/FCF	9.00x	17.96x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	8.72x	6.60x
Forward P/S (NTM)	2.37x	1.33x
Revenue & Growth
Revenue (TTM)	$49.19B	$14.74B
Revenue Growth (YoY)	38.5%	4.4%
Forward Rev Growth	-3.1%	2.0%
Profitability
Gross Margin (TTM)	71.7%	40.3%
Operating Margin (TTM)	25.5%	0.0%
EBITDA Margin (TTM)	46.1%	27.2%
Net Margin (TTM)	18.9%	-2.8%
FCF Margin (TTM)	33.9%	12.3%
Net Income (TTM)	$9.28B	$-411M
FCF (TTM)	$16.69B	$1.81B
EPS (TTM)	$4.53	-$0.35
ROE (TTM)	46.8%	-279.0%
ROA (TTM)	10.3%	-112.0%
ROIC (TTM)	14.2%	-142.0%
Financial Health
Cash	$8.72B	$887M
Debt	$43.12B	$13.35B
Net Cash/Debt	$-34.40B	$-12.46B
Current Ratio (TTM)	1.53x	1.58x
Quick Ratio (TTM)	1.39x	0.83x
Debt/Equity (TTM)	1.93x	0.94x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.18	0.89
52W Performance	28.9%	77.1%
YTD Performance	6.0%	38.4%
% from 52W High	-17.4%	-6.4%
% from 52W Low	33.3%	77.3%
Efficiency & Yields
Asset Turnover (TTM)	0.54x	0.40x
FCF Yield (TTM)	14.4%	9.0%
Earnings Yield (TTM)	8.0%	-2.0%
Dividend Yield (TTM)	6.3%	2.7%
Other
Rule of 40	72.5	16.7
EV/GP/RG	N/A	1.97
Ticker research	View BMY research	View VTRS research

Valuation

P/E Ratio

BMY

12.50x

P/S Ratio

VTRS

1.36x

BMY

2.35x

EV/FCF

BMY

9.00x

VTRS

17.96x

Growth & revenue

Revenue Growth TTM

BMY

38.5%

VTRS

4.4%

Forward Revenue Growth

VTRS

2.0%

BMY

-3.1%

Profitability & performance

Gross Margin

BMY

71.7%

VTRS

40.3%

ROE

BMY

46.8%

VTRS

-279.0%

FCF Yield %

BMY

14.4%

VTRS

9.0%

52-Week Performance

VTRS

77.1%

BMY

28.9%

Detailed metrics comparison

BMY

Bristol-Myers Squibb Co

VTRS

Viatris Inc

Market Cap

BMY$115.72B

VTRS$20.09B

Enterprise Value

BMY$150.12B

VTRS$32.55B

Price

BMY$56.67

VTRS$17.25

P/E Ratio

BMY12.50x

VTRSN/A

P/S Ratio

BMY2.35x

VTRS1.36x

EV/Sales

BMY3.05x

VTRS2.21x

EV/EBITDA

BMY6.41x

VTRS8.00x

P/B Ratio

BMY5.41x

VTRS1.42x

P/FCF Ratio

BMY6.93x

VTRS11.09x

EV/FCF

BMY9.00x

VTRS17.96x

PEG Ratio

BMYN/A

VTRSN/A

Forward P/E (NTM)

BMY8.72x

VTRS6.60x

Forward P/S (NTM)

BMY2.37x

VTRS1.33x

Revenue (TTM)

BMY$49.19B

VTRS$14.74B

Revenue Growth (YoY)

BMY38.5%

VTRS4.4%

Forward Rev Growth

BMY-3.1%

VTRS2.0%

Gross Margin (TTM)

BMY71.7%

VTRS40.3%

Operating Margin (TTM)

BMY25.5%

VTRS0.0%

EBITDA Margin (TTM)

BMY46.1%

VTRS27.2%

Net Margin (TTM)

BMY18.9%

VTRS-2.8%

FCF Margin (TTM)

BMY33.9%

VTRS12.3%

Net Income (TTM)

BMY$9.28B

VTRS$-411M

FCF (TTM)

BMY$16.69B

VTRS$1.81B

EPS (TTM)

BMY$4.53

VTRS-$0.35

ROE (TTM)

BMY46.8%

VTRS-279.0%

ROA (TTM)

BMY10.3%

VTRS-112.0%

ROIC (TTM)

BMY14.2%

VTRS-142.0%

Cash

BMY$8.72B

VTRS$887M

Debt

BMY$43.12B

VTRS$13.35B

Net Cash/Debt

BMY$-34.40B

VTRS$-12.46B

Current Ratio (TTM)

BMY1.53x

VTRS1.58x

Quick Ratio (TTM)

BMY1.39x

VTRS0.83x

Debt/Equity (TTM)

BMY1.93x

VTRS0.94x

Debt/Assets (TTM)

BMY0.0%

VTRS0.0%

Interest Coverage (TTM)

BMYN/A

VTRSN/A

Net Debt/EBITDA (TTM)

BMY0.00x

VTRS0.00x

Beta

BMY0.18

VTRS0.89

52W Performance

BMY28.9%

VTRS77.1%

YTD Performance

BMY6.0%

VTRS38.4%

% from 52W High

BMY-17.4%

VTRS-6.4%

% from 52W Low

BMY33.3%

VTRS77.3%

Asset Turnover (TTM)

BMY0.54x

VTRS0.40x

FCF Yield (TTM)

BMY14.4%

VTRS9.0%

Earnings Yield (TTM)

BMY8.0%

VTRS-2.0%

Dividend Yield (TTM)

BMY6.3%

VTRS2.7%

Rule of 40

BMY72.5

VTRS16.7

EV/GP/RG

BMYN/A

VTRS1.97

Ticker research

View BMY research View VTRS research

Metric	BMY Bristol-Myers Squibb Co	VTRS Viatris Inc
Market & Valuation
Market Cap	$115.72B	$20.09B
Enterprise Value	$150.12B	$32.55B
Price	$56.67	$17.25
P/E Ratio	12.50x	N/A
P/S Ratio	2.35x	1.36x
EV/Sales	3.05x	2.21x
EV/EBITDA	6.41x	8.00x
P/B Ratio	5.41x	1.42x
P/FCF Ratio	6.93x	11.09x
EV/FCF	9.00x	17.96x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	8.72x	6.60x
Forward P/S (NTM)	2.37x	1.33x
Revenue & Growth
Revenue (TTM)	$49.19B	$14.74B
Revenue Growth (YoY)	38.5%	4.4%
Forward Rev Growth	-3.1%	2.0%
Profitability
Gross Margin (TTM)	71.7%	40.3%
Operating Margin (TTM)	25.5%	0.0%
EBITDA Margin (TTM)	46.1%	27.2%
Net Margin (TTM)	18.9%	-2.8%
FCF Margin (TTM)	33.9%	12.3%
Net Income (TTM)	$9.28B	$-411M
FCF (TTM)	$16.69B	$1.81B
EPS (TTM)	$4.53	-$0.35
ROE (TTM)	46.8%	-279.0%
ROA (TTM)	10.3%	-112.0%
ROIC (TTM)	14.2%	-142.0%
Financial Health
Cash	$8.72B	$887M
Debt	$43.12B	$13.35B
Net Cash/Debt	$-34.40B	$-12.46B
Current Ratio (TTM)	1.53x	1.58x
Quick Ratio (TTM)	1.39x	0.83x
Debt/Equity (TTM)	1.93x	0.94x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.18	0.89
52W Performance	28.9%	77.1%
YTD Performance	6.0%	38.4%
% from 52W High	-17.4%	-6.4%
% from 52W Low	33.3%	77.3%
Efficiency & Yields
Asset Turnover (TTM)	0.54x	0.40x
FCF Yield (TTM)	14.4%	9.0%
Earnings Yield (TTM)	8.0%	-2.0%
Dividend Yield (TTM)	6.3%	2.7%
Other
Rule of 40	72.5	16.7
EV/GP/RG	N/A	1.97
Ticker research	View BMY research	View VTRS research